. In all nine eyes, UBM at 1 month after surgery showed a subconjunctival filtration through the thin trabeculocorneal membrane and through the scleral flap around the collagen implant. In four cases, a hypoechoic area in the suprachoroidal space was observed and might represent ciliary body detachment or be due to suprachoroidal drainage of aqueous humour through the thin deep scleral wall. At 1 month after surgery the mean trabeculocorneal membrane thickness was 110.1 (16.8) rm, and the mean length and height of the collagen implant were 2.3 (0.1) mm and 1.1 (0.1) mm respectively. Conclusion-DSCI lowered lOP by allowing aqueous filtration through a thin trabeculocorneal membrane to the subconjunctival space and, eventually, to the suprachoroidal space. (BrJ Ophthalmol 1996;80:541-544) Deep sclerectomy with collagen implant (DSCI), a non-penetrating glaucoma surgery, was first described by Kozlov et al in 1989.' In this technique, a deep sclerectomy with thinning of the adjacent trabeculum and limbal cornea is performed. Although still under investigation, this procedure seems to be promising as it lowers the intraocular pressure (IOP) without perforation of the anterior chamber, thus reducing the occurrence of postoperative complications.
Methods-Nine eyes of nine patients with medically uncontrolled open angle glaucoma underwent DSCI. Ultrasound biomicroscopy (UBM) of the sclerectomy site was performed 1 month after surgery. The following factors were assessed: length and height of collagen implant, and thickness of the residual trabeculocorneal membrane. Results-Postoperative IOP decreased significantly in all nine eyes from a preoperative mean value of 25.8 (SD 4.8) mm Hg to a postoperative (1 month) mean value of 11.3 (6.3) mm Hg (p=0.001). In all nine eyes, UBM at 1 month after surgery showed a subconjunctival filtration through the thin trabeculocorneal membrane and through the scleral flap around the collagen implant. In four cases, a hypoechoic area in the suprachoroidal space was observed and might represent ciliary body detachment or be due to suprachoroidal drainage of aqueous humour through the thin deep scleral wall. At 1 month after surgery the mean trabeculocorneal membrane thickness was 110. 1 (16.8) ' unroofed', and the corneal stroma was removed anteriorly down to the Descemet's membrane. At that stage of the procedure, aqueous humour was percolating through the thin trabecular corneal membrane. The collagen implant (Staar Surgica AG, Nidau, Switzerland) was then secured to the deep sclera by placing a 10/0 nylon suture at the midpoint of the triangular bed. The rectangular scleral flap was then closed and sutured with two 10/0 nylon sutures. The Tenon's capsule and the conjunctiva were closed with separate 8/0 silk sutures. Neither 5-fluorouracil nor mitomycin C had been used. Postoperatively the patients were treated with topical application of dexamethasone, neomycin, and polymyxin B drops (Maxitrol) four times daily for 1 month, followed by fluorometholone drops (Efemoline) three times daily for 5 months.
COLLAGEN IMPLANT
The device is manufactured from microporous crosslinked collagen harvested from porcine sclera. In its dry state, the collagen device measures approximately 2.5 mm x 1.0 mm x 0. (2) drainage of aqueous through the scleralflap, (3) conjunctival bleb. In all nine eyes, UBM showed a subconjunctival filtration through the thin trabeculocorneal membrane and through the scleral flap around the collagen implant (Figs 1, 2, and 3) .
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In four cases, a suprachoroidal hypoechoic area was clearly observed under the sclerectomy site as represented in Figure 4 . After exclusion of the eye with a corticosteroid response, the four eyes with a hypoechoic area had a lower postoperative IOP compared with the four other eyes (mean IOP 6.3 (1.7) mm Hg versus 13 (1.2) mm Hg, p=0.001).
Ultrasound biomicroscopy of eyes undergoing deep sclerectomy with collagen implant 
Discussion
The main advantage of DSCI over standard trabeculectomy is the non-perforation of the anterior chamber, allowing a progressive decrease of IOP and, thus, lowering the occurrence of complications such as hyphaema, flat anterior chamber, and anterior chamber inflammation. The collagen implant is slowly dissolved within 3 to 6 months and replaced by new autologous scleral tissue, leaving a tunnel in the sclera. In order to study the IOP lowering mechanism of DSCI, the use of a high resolution device, such as the ultrasound biomicroscope, was necessary.
In eight eyes, IOP decreased significantly 1 month after surgery. One eye presented a high postoperative IOP because of a corticosteroid response. This complication may occur after a successful filtering surgery, as described previously after trabeculectomy4 or implantation of a Molteno tube. ' UBM imaging showed that DSCI lowered IOP by allowing aqueous filtration through a thin remaining trabeculocorneal membrane to UBM was performed 1 month after surgery. Therefore, the thickness of the trabeculocorneal membrane, and the length and height of the collagen implant represented single measurements. These factors may vary in time, and further studies are needed to assess the structural evolution of eyes undergoing DSCI. Measurements using electronic calipers on a screen may be accurate provided the measurements are made in axis with the beam or perpendicular to the beam. In this study the measurements of the height and width of the implant could be considered to be accurate. However, the residual trabeculocorneal membrane is angled to the transducer and of a size approaching the minimum resolvable measurement of the instrument. Its value should be considered as an approximation.
DSCI represents a delicate microsurgical technique that requires surgical skills. The main difficulty is to perform the dissection of the deep sclera and to avoid a perforation ofthe remaining trabeculocorneal membrane. As aqueous humour has to reach the iridocorneal angle to filter through the trabeculocorneal membrane and because in this procedure no iridectomy is performed, DSCI is not recommended in patients with angle closure glaucoma.
UBM was a useful method of assessing the anatomical results of eyes undergoing DSCI and allowed us to understand the aqueous humour outflow mechanism of this new, non-perforating filtration surgery 1 month after surgery. Further studies are needed to assess the long term functional and anatomical results of DSCI.
